Bioactivity:

Atezolizumab anti-PD-L1) is a fully humanized IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1 but not the interaction of PD-L2 with PD-1.

CAS nr:

1380723-44-3

Purity:

98%

Molecular Weight:

145000

SMILES:

Formula:

Pathway:

Immunology/Inflammation,Cell Cycle/Checkpoint,Apoptosis,Autophagy,Apoptosis

Target:

PD-1/PD-L1,PD-1/PD-L1,PD-1/PD-L1,Autophagy,Apoptosis